Thrombolytic Therapy For Acute Stroke

Stroke is a major cause of death and disability in the United States and worldwide. While intravenous tissue plasminogen activator (tPA) can effectively treat acute ischemic stroke, few patients receive it due to its narrow time window and contraindications. Endovascular therapies including mechanical clot retrieval may extend the treatment window and benefit more patients, especially those with severe or large vessel strokes. New devices and techniques continue to improve revascularization rates and outcomes for acute stroke.